Table 5.
Model Validation Summary
| Perturbation | Experimental observations | Simulation design | Simulation result | Comments |
|---|---|---|---|---|
| Food consumption | Total, conjugated BAs↑, FGF-19↑, C4↓ in the systemic plasma9 | Default parameter values | ∼2-fold total BA↑, driven by conjugated BAs, ∼35% FGF-19↑ and 70% C4↓ in systemic plasma (Figure 3) | Gallbladder emptying depends on food fat content18; hence, parameter kemptGB can be changed to reflect different food types |
| Fasting (short term) | Total BAs and FGF-19↓, C4↑ in the systemic plasma34 | Time-dependent functions are fixed on fasting values: = 0, = 1, = 1, = 1 |
∼2-fold total BA↓, 2.75-fold C4↑, and 60% FGF-19↓ in systemic plasma (Figure 6) | Additional modifications are required to reproduce prolonged fasting (1) - parameter ksyn should be decreased to reflect BA synthesis reduction55; (2) rate VfillGB should be modified to limit gallbladder filling |
| SIBO | Total and unconjugated BAs↑ in systemic plasma54 | 10-fold increase in parameter kdcjLINT, from default value | ∼2.2-fold total BAs↑ in systemic plasma (Figure 4) | Deconjugation and unconjugated BA absorption in the duodenojejunal compartment should be introduced to reflect severe SIBO |
| BA malabsorption (after ileostomy or cholestiramine treatment) | FGF-19↓ and C4↑ in systemic plasma, increased fecal BA loss5 | Parameter fabsLINTvariation from default value to 0 | Up to 25-fold total colonic BA ↑, up to 16-fold systemic C4↑ (Figure 5) | Parameters ktrintcol, kexcan be modified to reflect accelerated colonic motility in patients with BA-induced diarrhea5 |
| Antibiotic treatment | Secondary BAs↓ in systemic plasma43 | 10-fold decrease in parameter kdcjCOL, from default value | ∼7-fold DCA fraction ↓ (Figure 4) | – |
| Cholecystectomy | Preservation of meal-induced daily BA oscillations, CA and CDCA pool↓33 | Parameter was nullified, parameter kdcjLINT was changed for patients with SIBO/CST | Preservation of meal-induced BA-oscillations, no change in CA and CDCA fractions (Figure 7) | – |
SIBO, small intestine bacterial overgrowth.